DDenmark Read More Denmark: Samfara completes acquisition of Chr Olesen Synthesis2026-10-02 Samfara, a London-based European life sciences investment firm, has completed the acquisition of Denmark-based Chr Olesen Synthesis from…
BBerlin Read More Berlin and Paris Lock Up 80% of KNDS as €20bn IPO Hinges on PwC Clean Bill2026-05-23 Germany and France will control 80% of KNDS at its 2026 IPO, leaving only a sliver for investors.…